PAR paradigm biopharmaceuticals limited..
Add to My Watchlist 0.00% ! 29.0¢

Ann: March 2025 Quarterly Activities Report & Appendix 4C, page-5

  1. Mozzarc
    4,840 Posts.
    lightbulb Created with Sketch. 7527
    clock Created with Sketch.
    29/04/25
    14:26
    Post #: 78842079
    Yes, it is just too risky just to start without some basic sense that funding should be forthcoming, but thats only my spec thoughts.

    What is reality, we gotta wait for that.


    PAR Price at posting: 30.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
29.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $112.9M
Open High Low Value Volume
28.5¢ 29.5¢ 28.0¢ $124.5K 435.8K

Buyers (Bids)

No. Vol. Price($)
2 13421 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 13706 1
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.